Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation
Following a surgical procedure, patients may experience complications, such as a surgical site infection (SSI). The Centers for Disease Control and Prevention (CDC) define a SSI as an incisional or organ space infection which occurs following a surgical procedure. The severity is then classified as a superficial, deep or organ space infection, occurring within 30 days of surgery. Despite improvements in patient care and a variety of available preoperative, intraoperative and postoperative infection prevention strategies, SSIs still occur very frequently. They account for 20% of hospital infections and are associated with important economic and patient outcomes such as morbidity, mortality and length of stay. It is estimated that over half (55%) of SSIs could be prevented. One proposed intervention to reduce SSIs is the intraoperative irrigation of incisional wounds. By washing a solution over an open wound, debris, bacteria and bodily fluids may be removed prior to wound closure at the end of a procedure. Although many studies have been conducted, uncertainty remains with respect to the following: 1) the need for irrigation; 2) the solution used to irrigate; 3) the method of irrigation (i.e. pour, syringe, pressure and/or pulsed delivery); and 4) the volume of irrigation, leading to conflicting guidelines and practice heterogeneity. In this trial, adult patients scheduled to undergo an elective abdominal open or laparoscopic procedure will be randomly assigned to incisional wound irrigation with povidone-iodine solution; or incisional wound irrigation with saline; or no irrigation. This trial will be conducted under the IMPACTS (Innovative, Multicentre, Patient-centred Approach to Clinical Trials in Surgery) program umbrella and will follow IMPACTS methodology. For the Vanguard trial, the aim is to determine the feasibility of conducting a definitive trial. Future outcomes of interest include surgical site infection and quality of life, among others.
Start: January 2021